Top-News

Novogen ADR News

Keine aktuellen Kursdaten verfügbar
WKN: A1JRKZ
ISIN: US67010F2020
Typ: Aktie

Novogen ADR News

11.12.19 - PR Newswire
Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma
Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma PR Newswire
11.12.19 - PR Newswire
Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma
Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma PR Newswire
12.09.19 - PR Newswire
St Jude Study of GDC-0084 in DIPG Successfully Completes First Stage; Second Part of Study Now Underway
St Jude Study of GDC-0084 in DIPG Successfully Completes First Stage; Second Part of Study Now Underway PR Newswire
22.07.19 - PR Newswire
Kazia to test GDC-0084 with Radiotherapy in Phase I Clinical Trial at Leading US Cancer Center
Kazia to test GDC-0084 with Radiotherapy in Phase I Clinical Trial at Leading US Cancer Center PR Newswire
22.08.17 - PR Newswire
GDC-0084 Progress Update: On Track for Phase II Commencement in 2017
GDC-0084 Progress Update: On Track for Phase II Commencement in 2017 PR Newswire
14.08.17 - PR Newswire
Board Review of Business Operations and Governance
Board Review of Business Operations and Governance - Board and management have reviewed business operations following appointment of new Chairman in June 2017 and ...
07.08.17 - PR Newswire
Progress Update on Cantrixil(TM) (TRXE-002-1) Development
Progress Update on Cantrixil(TM) (TRXE-002-1) Development - Phase I clinical trial in ovarian cancer progressing as planned - Second batch of Cantrixil planned to be ...
10.03.17 - PR Newswire
Transformation to a Clinical Stage Organisation Leads to Changes in Management Structure
Transformation to a Clinical Stage Organisation Leads to Changes in Management Structure PR Newswire
10.03.17 - PR Newswire
Transformation to a Clinical Stage Organisation Leads to Changes in Management Structure
Transformation to a Clinical Stage Organisation Leads to Changes in Management Structure PR Newswire
06.03.17 - PR Newswire
Novogen Awarded Grant of up to A$3m by Australian Federal Government for Novel Drug Discovery Program
Novogen Awarded Grant of up to A$3m by Australian Federal Government for Novel Drug Discovery Program PR Newswire
30.10.16 - PR Newswire
Novogen Licenses Phase II-Ready Molecule from Genentech for Development in Glioblastoma
Novogen Licenses Phase II-Ready Molecule from Genentech for Development in Glioblastoma PR Newswire
30.10.16 - PR Newswire
Novogen Acquires Privately-held Neuro-oncology Company to Support Development of GDC-0084 in Glioblastoma
Novogen Acquires Privately-​held Neuro-​oncology Company to Support Development of GDC-0084 in Glioblastoma - Glioblast Pty Ltd, a privately-​held neuro-​oncology company ...
30.10.16 - PR Newswire
Novogen Licenses Phase II-Ready Molecule from Genentech for Development in Glioblastoma
Novogen Licenses Phase II-Ready Molecule from Genentech for Development in Glioblastoma - Licensing of GDC-0084, a small molecule phosphoinositide-3-kinase (PI3K) ...
14.09.16 - PR Newswire
Conversion of Convertible Notes
Conversion of Convertible Notes PR Newswire
12.09.16 - PR Newswire
US FDA Approves Investigational New Drug (IND) Application for Cantrixil(TM) (TRX-E-002-1) in Ovarian Cancer
US FDA Approves Investigational New Drug (IND) Application for Cantrixil(TM) (TRX-E-002-1) in Ovarian Cancer PR Newswire
11.08.16 - PR Newswire
Novogen Submits Investigational New Drug (IND) Application to the US FDA For Cantrixil(TM) in Ovarian Cancer
Novogen Submits Investigational New Drug (IND) Application to the US FDA For Cantrixil(TM) in Ovarian Cancer - Cantrixil (TRX-E-002-1) is Novogen's lead development candidate, ...
14.06.16 - PR Newswire
Novogen Patent Covering Anisina(TM) Has Proceeded to Grant
Novogen Patent Covering Anisina(TM) Has Proceeded to Grant - Cornerstone patent covering Anisina (ATM-3507) granted in Australia - Patent provides composition of matter, ...
02.05.16 - PR Newswire
Novogen Provides Update On Development Of Cantrixil
Novogen Provides Update On Development Of Cantrixil PR Newswire
16.03.16 - PR Newswire
Novogen Receives R&D Tax Incentive Cash Refund
Novogen Receives R&D Tax Incentive Cash Refund PR Newswire
19.02.16 - PR Newswire
Novogen Patent Covering Cantrixil And Trilexium Has Proceeded To Grant
Novogen Patent Covering Cantrixil And Trilexium Has Proceeded To Grant - Cornerstone patent covering Cantrixil and Trilexium granted in Australia - Patent provides composition of ...

Newssuche

Videos

26.04.24
Technical Trading: Gold Long freitags
Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »